P-selectin glycoprotein ligand-1

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 05:55, March 30, 2023 by Notjusttired (talk | contribs) (Text replacement - " | doi =" to " | doi =")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

A study by Griffith University found that CD8+ T cells exhibited significantly decreased CD127 and PSGL-1[1]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ Brenu, EW; Broadley, S; Nguyen, T; Johnston, S; Ramos, S; Staines, D; Marshall-Gradisnik, S (January 4, 2016), "A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis", Journal of Immunology Research, 2016: 9064529, doi:10.1155/2016/9064529
Retrieved from "https://me-pedia.org/w/index.php?title=P-selectin_glycoprotein_ligand-1&oldid=224018"